Vicarious Surgical Inc (RBOT)
0.43
+0.10
(+30.26%)
USD |
NYSE |
May 17, 16:00
0.428
0.00 (0.00%)
After-Hours: 20:00
Vicarious Surgical Cash from Investing (Quarterly): -0.144M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.144M |
| December 31, 2023 | 5.045M |
| September 30, 2023 | -0.644M |
| June 30, 2023 | -6.356M |
| March 31, 2023 | -43.83M |
| December 31, 2022 | -0.992M |
| September 30, 2022 | -0.782M |
| Date | Value |
|---|---|
| June 30, 2022 | -1.556M |
| March 31, 2022 | -2.022M |
| December 31, 2021 | -0.867M |
| September 30, 2021 | -0.082M |
| June 30, 2021 | -0.212M |
| March 31, 2021 | -0.128M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-43.83M
Minimum
Mar 2023
5.045M
Maximum
Dec 2023
-4.044M
Average
-0.782M
Median
Sep 2022
Cash from Investing (Quarterly) Benchmarks
| Ekso Bionics Holdings Inc | -0.008M |
| Perspective Therapeutics Inc | -0.089M |
| Xtant Medical Holdings Inc | -2.313M |
| Asensus Surgical Inc | 3.00M |
| Catheter Precision Inc | -0.022M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -14.46M |
| Cash from Financing (Quarterly) | 0.002M |
| Free Cash Flow | -59.57M |
| Free Cash Flow Per Share (Quarterly) | -0.0823 |
| Free Cash Flow Yield | -87.50% |